Jan-Samuel Wagner

1.3k total citations
22 papers, 959 citations indexed

About

Jan-Samuel Wagner is a scholar working on General Health Professions, Epidemiology and Hepatology. According to data from OpenAlex, Jan-Samuel Wagner has authored 22 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in General Health Professions, 6 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Jan-Samuel Wagner's work include Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (4 papers). Jan-Samuel Wagner is often cited by papers focused on Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (4 papers). Jan-Samuel Wagner collaborates with scholars based in United States, Japan and United Kingdom. Jan-Samuel Wagner's co-authors include Marco DiBonaventura, Jennifer Whiteley, José Alvir, Sonali Shah, Reema Mody, Shawn X. Sun, Yong Yuan, Paul C. Langley, Omar Dabbous and Gilbert L’Italien and has published in prestigious journals such as Journal of Hepatology, Digestive Diseases and Sciences and JAMA Oncology.

In The Last Decade

Jan-Samuel Wagner

22 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan-Samuel Wagner United States 14 260 202 146 143 140 22 959
Perrie E. Pardee United States 8 405 1.6× 79 0.4× 674 4.6× 240 1.7× 55 0.4× 8 1.2k
Elza Daniel de Mello Brazil 18 81 0.3× 39 0.2× 99 0.7× 154 1.1× 235 1.7× 119 1.3k
Chih‐Kun Huang Taiwan 24 188 0.7× 251 1.2× 161 1.1× 1.3k 9.2× 47 0.3× 94 1.8k
Clyve Yu Leon Yaow Singapore 16 99 0.4× 63 0.3× 126 0.9× 173 1.2× 52 0.4× 36 658
Mazen Ferwana Saudi Arabia 14 141 0.5× 68 0.3× 69 0.5× 198 1.4× 153 1.1× 37 892
Keiko Kazuma Japan 20 99 0.4× 20 0.1× 196 1.3× 141 1.0× 220 1.6× 67 1.2k
Paweł Matusik Poland 17 228 0.9× 15 0.1× 198 1.4× 129 0.9× 92 0.7× 58 855
William Reichel United States 17 36 0.1× 112 0.6× 74 0.5× 233 1.6× 74 0.5× 49 831
Robert W. Baran United States 14 140 0.5× 55 0.3× 120 0.8× 70 0.5× 108 0.8× 43 674
Lindsay Govan United Kingdom 20 190 0.7× 15 0.1× 302 2.1× 188 1.3× 87 0.6× 30 1.0k

Countries citing papers authored by Jan-Samuel Wagner

Since Specialization
Citations

This map shows the geographic impact of Jan-Samuel Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan-Samuel Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan-Samuel Wagner more than expected).

Fields of papers citing papers by Jan-Samuel Wagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan-Samuel Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan-Samuel Wagner. The network helps show where Jan-Samuel Wagner may publish in the future.

Co-authorship network of co-authors of Jan-Samuel Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Jan-Samuel Wagner. A scholar is included among the top collaborators of Jan-Samuel Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan-Samuel Wagner. Jan-Samuel Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atkinson, Thomas M., Jan-Samuel Wagner, & Ethan Basch. (2016). Trustworthiness of Patient-Reported Outcomes in Unblinded Cancer Clinical Trials. JAMA Oncology. 3(6). 738–738. 42 indexed citations
2.
Whiteley, Jennifer, et al.. (2013). Impact of the severity of vasomotor symptoms on health status, resource use, and productivity. Menopause The Journal of The North American Menopause Society. 20(5). 518–524. 107 indexed citations
3.
Wagner, Jan-Samuel, Arthi Chandran, Marco DiBonaventura, & Joseph C. Cappelleri. (2013). The costs associated with sleep symptoms among patients with fibromyalgia. Expert Review of Pharmacoeconomics & Outcomes Research. 13(1). 131–139. 6 indexed citations
4.
Whiteley, Jennifer, Marco DiBonaventura, Jan-Samuel Wagner, José Alvir, & Sonali Shah. (2013). The Impact of Menopausal Symptoms on Quality of Life, Productivity, and Economic Outcomes. Journal of Women s Health. 22(11). 983–990. 194 indexed citations
5.
Wagner, Jan-Samuel, Marco DiBonaventura, Arthi Chandran, & Joseph C. Cappelleri. (2012). The association of sleep difficulties with health-related quality of life among patients with fibromyalgia. BMC Musculoskeletal Disorders. 13(1). 199–199. 41 indexed citations
6.
DiBonaventura, Marco, Yong Yuan, Jan-Samuel Wagner, et al.. (2012). The burden of viral hepatitis C in Europe. European Journal of Gastroenterology & Hepatology. 24(8). 869–877. 28 indexed citations
7.
DiBonaventura, Marco, Ryne Paulose‐Ram, Margaret V. McDonald, et al.. (2012). The burden of chronic obstructive pulmonary disease among employed adults. International Journal of COPD. 7. 211–211. 38 indexed citations
8.
DiBonaventura, Marco, Jan-Samuel Wagner, José Alvir, & Jennifer Whiteley. (2012). Depression, Quality of Life, Work Productivity, Resource Use, and Costs Among Women Experiencing Menopause and Hot Flashes. The Primary Care Companion For CNS Disorders. 14(6). 24 indexed citations
9.
DiBonaventura, Marco, Ryne Paulose‐Ram, Jun Su, et al.. (2012). The Impact of COPD on Quality of Life, Productivity Loss, and Resource Use among the Elderly United States Workforce. COPD Journal of Chronic Obstructive Pulmonary Disease. 9(1). 46–57. 37 indexed citations
10.
Liu, Gordon G., Marco DiBonaventura, Yong Yuan, et al.. (2012). The Burden of Illness for Patients with Viral Hepatitis C: Evidence from a National Survey in Japan. Value in Health. 15(1). S65–S71. 57 indexed citations
11.
12.
Yuan, Yuping, et al.. (2011). 1192 THE BURDEN OF VIRAL HEPATITIS C IN EUROPE: A PROPENSITY ANALYSIS OF PATIENT OUTCOMES. Journal of Hepatology. 54. S471–S471. 1 indexed citations
13.
Wagner, Jan-Samuel, Marco DiBonaventura, Sonali Shah, José Alvir, & Jennifer Whiteley. (2011). PIH32 THE ASSOCIATION OF MENOPAUSAL SYMPTOMS, INCLUDING HOT FLASHES, WITH QUALITY OF LIFE, WORK PRODUCTIVITY AND RESOURCE USE. Value in Health. 14(3). A111–A111. 1 indexed citations
14.
DiBonaventura, Marco, Jan-Samuel Wagner, Yong Yuan, et al.. (2011). The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. Journal of Medical Economics. 14(2). 253–261. 56 indexed citations
15.
16.
Wagner, Jan-Samuel, Marco DiBonaventura, Sanjeev Balu, & Deborah Buchner. (2011). The burden of diurnal and nocturnal gastroesophageal reflux disease symptoms. Expert Review of Pharmacoeconomics & Outcomes Research. 11(6). 739–749. 2 indexed citations
17.
DiBonaventura, Marco, Shawn X. Sun, S. Bolge, Jan-Samuel Wagner, & Reema Mody. (2011). Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome. Current Medical Research and Opinion. 27(11). 2213–2222. 60 indexed citations
18.
DiBonaventura, Marco, Charles R. Link, Michael Pollack, Jan-Samuel Wagner, & Setareh A. Williams. (2011). The Relationship Between Patient-Reported Tolerability Issues With Oral Antidiabetic Agents and Work Productivity Among Patients Having Type 2 Diabetes. Journal of Occupational and Environmental Medicine. 53(2). 204–210. 13 indexed citations
19.
DiBonaventura, Marco, et al.. (2010). The association of well-being, productivity and resource use among community-dwelling patients with schizophrenia using atypical antipsychotics. Journal of Pharmaceutical Health Services Research. 1(4). 181–187. 2 indexed citations
20.
DiBonaventura, Marco, Jan-Samuel Wagner, Yong Yuan, et al.. (2010). Humanistic and economic impacts of hepatitis C infection in the United States. Journal of Medical Economics. 13(4). 709–718. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Perrie E. Pardee Breakdown of academic impact, for papers by Elza Daniel de Mello Breakdown of academic impact, for papers by Chih‐Kun Huang Breakdown of academic impact, for papers by Clyve Yu Leon Yaow Breakdown of academic impact, for papers by Mazen Ferwana Breakdown of academic impact, for papers by Keiko Kazuma Breakdown of academic impact, for papers by Paweł Matusik Breakdown of academic impact, for papers by William Reichel Breakdown of academic impact, for papers by Robert W. Baran Breakdown of academic impact, for papers by Lindsay Govan
Rankless by CCL
2026